The impact of a school-based multicomponent intervention for promoting vaccine uptake in Italian adolescents: a retrospective cohort study by Poscia, Andrea et al.
O
r
ig
in
a
l
 a
r
t
ic
l
e
s
 a
n
d
 r
e
v
ie
w
s
124
Key words
• immunization
• school
• adolescents
• students
• vaccine uptake
The impact of a school-based 
multicomponent intervention  
for promoting vaccine uptake in Italian 
adolescents: a retrospective cohort study
Andrea Poscia1,2, Roberta Pastorino1, Stefania Boccia1,3, Walter Ricciardi1,4  
and Antonietta Spadea5 
1Sezione di Igiene, Istituto di Sanità Pubblica, Università Cattolica del Sacro Cuore, Rome, Italy 
2ASUR Marche – AV2 – UOC ISP Prevenzione e Sorveglianza Malattie Infettive  
e Cronico Degenerative, Jesi (Ancona), Italy 
3Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy 
4Istituto Superiore di Sanità, Rome, Italy 
5Azienda Sanitaria Locale, ASL Roma 1, Rome, Italy
Ann Ist Super Sanità 2019 | Vol. 55, No. 2: 124-130
DOI: 10.4415/ANN_19_02_04
Abstract
Background. In Italy, the National Immunization Prevention Plan recommends for ado-
lescents between ages 11 and 18 several vaccines, however their adherence is below the 
expected coverage. School-based delivery strategies might represent an alternative to 
primary care settings. This study aims to evaluate the impact of a school-based interven-
tion aimed to increase the vaccination uptake among Italian secondary class students.
Methods. One of the four schools in which a school-based multicomponent interven-
tion was previously carried out has been matched with a control school in the same 
geographical area. Students’ coverage for mandatory and recommended vaccinations 
was assessed before and after an 8 months period using the Local Health Authority Im-
munization Register.
Results. Seven hundred and fifty-five resident students in the RM Local Health Author-
ity were included: 265 from the intervention school, 490 from the control school. At 
baseline, the two schools were comparable for grades and sex distribution; the interven-
tion school had significant higher immunization rates for Meningococcal B, but lower 
ones for the 4th dose of dTap. After eight months, higher percentage of students received 
the HPV (30.5% vs 13.8% of females; p = 0.003) Meningococcal C (6.0% vs 2.0%; p = 
0.005) and Meningococcal B (14.7% vs 0.3%; p <0.001) vaccines in the intervention 
school compared with control. The pre-post differences between the two schools in the 
immunization rates were significantly higher in the intervention school for the HPV, 
Meningococcal C and B vaccines. 
Conclusions.This study demonstrates that a school-based health promotion project was 
effective in improving the recommended vaccines uptake among adolescents with po-
tential interesting implication for the national target attainment. Considering the impor-
tance of informing and educating, innovative school-based health promotion programs 
could represent an excellent opportunity for the Local Health Authorities to get in touch 
with a hard-to-reach target. Performance in offering the vaccination in school facilities 
should be evaluated.
INTRODUCTION
Vaccines are universally recognized as one of the 
most effective instruments for the primary prevention 
of infectious diseases, but in recent years vaccination 
delay or refusal is putting at risk the high level of immu-
nization rates achieved in the past. This phenomenon, 
namely vaccine hesitancy, could be due to multiple lev-
els of factors that influence parental vaccine confidence 
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and acceptance [1]. Apart from the risk perception of 
the diseases and the confidence on vaccines, the WHO 
SAGE Working Group on Vaccine Hesitancy pointed 
out “convenience” as a possible explanation related to 
the ease of access to immunization in terms of location 
and time [2]. Immunizing adolescents represent global-
ly a struggle despite national routine recommendations. 
In Italy, the National Immunization Prevention Plan 
recommends for adolescents between 11 and 18 years 
the following vaccines: diphtheria, tetanus, and acel-
lular pertussis (dTpa), catch-up strategies for measles, 
mumps and rubella (MMR); Meningococcal C conju-
gate in subjects not vaccinated during childhood, two/
three-dose schedule against HPV (only for females); a 
two-dose schedule against varicella in subjects unvac-
cinated or with negative history for the disease [3]. 
Regardless, respectively 52.9%, 53.9%, 74.9%, 75.0% 
and 16.0% of 16 years old adolescents received the fifth 
dose of dTap, the second dose of MMR, the first dose 
of rubella and mumps and one dose of Meningococcal 
C [4]. HPV vaccine coverage rates ranged from 72.1% 
for the 1999 birth cohort to 52.4% for the 2002 birth 
cohort (even if the latter is not still definitive) [5]. The 
coverage for the remaining available vaccines is lower 
than 10%, in particular 2.4% for varicella [4]. 
With the availability of newer vaccines and greater at-
tention to providing booster doses of routine vaccines 
to older children, schools are becoming a more widely 
used platform for immunization [6]. In several coun-
tries, school-based health centres represent an alterna-
tive to primary care settings and have been shown to 
minimize common obstacles, such as parents missing 
work, therefore increasing immunization rates [7-10].
Despite the relevant success of the extraordinary 
measles catch-up campaign in several Regions, which 
include also the MMR vaccine delivery in elementary 
and middle schools, [11], Italy does not have a well-
structured school-based immunization program. Fur-
thermore, with the gradual shelving of the scholastic 
preventive medicine [12], Italian students are losing 
several opportunities to receive trustworthy informa-
tion regarding vaccination and, consequently, protec-
tion against vaccine preventable diseases. This kind of 
activity has been delegated to the paediatricians, which 
usually visit their older patients only if they have health 
issues. Eventually, the Local Health Authority, in re-
spect of its own autonomous organization, could imple-
ment voluntarily, but no more mandatory, school-based 
health promotion campaign, which are usually target 
to contrast non-communicable diseases, to promote 
healthy lifestyle and to fight dependencies. 
For all these reasons, the Public Health Institute of the 
Università Cattolica del Sacro Cuore of Rome decided 
to design a project called “VacciniAmo le Scuole” (Let’s 
school get vaccinated), which proposes to evaluate and 
enhance parents’ and students’ knowledge and attitudes 
of prevention regarding vaccine-preventable diseases in 
collaboration with the Italian Ministry of Education and 
the Local Health Authorities. Preliminary results pro-
vided further evidence about school-based health pro-
motion programs as an effective strategy for improving 
knowledge and attitudes about this issue [13]. 
Since the original study design did not consider a 
control group, definitive conclusions about the proj-
ect impact on the general vaccine coverage among the 
target population couldn’t be carried out. The present 
study aimed to overcome this limitation evaluating the 
impact of a school-based multicomponent intervention 
on the adherence of Italian secondary school students 
to adolescent recommended vaccination. In this study, 
we hypothesized that the school involved in the Vac-
cinAmo le Scuole project reported significantly higher 
rates of immunization of recommended vaccinations 
for adolescents compared with a school who did not 
receive the health promotion intervention (the control 
group).
METHODS
The intervention: VacciniAmo le Scuole project
The VacciniAmo le Scuole project was conducted in 
2015 in four secondary schools in three Italian Regions 
(Lazio, Basilicata and Sicily), with the support of the 
local health authorities (ASL Roma A (now ASL Roma 
1), ASL Roma B (now ASL Roma 2), ASM Matera 
and ASP Palermo). Each class received a 90 minutes 
health promotion intervention, which includes a theo-
retical introduction and a second part more interactive 
using the role-play technique, and a pre-post question-
naire [14]. Students’ parents received at home a similar 
questionnaire, which includes a section requesting their 
informed consent and invitation to a meeting with the 
project team. All the health promotion activities have 
been carried out in deep collaboration with each repre-
sentative of the local health authorities. After the school 
interventions, each Local Health Authority arranged to 
receive students and parents at least one day in their 
surgery to carry out the recommended vaccinations for 
adolescents. Detailed information regarding the project 
and its results are under submission separately. The Vac-
ciniAmo Le Scuole project was approved by the Ethical 
Committee of the Local Health Authorities “Roma 1” 
(Ref. n. 513 CE Lazio1 – Rome, 02/03/2017).
Study design and schools recruitment
The impact of the school-based multicomponent 
intervention VacciniAmo le Scuole was tested using a 
retrospective cohort design, comparing the aggregated 
immunization coverage in one of the schools in which 
the VacciniAmo le Scuole has been performed (inter-
vention school) to a matched school from the same geo-
graphical area. 
The intervention school was selected from the four 
schools participating in the VacciniAmo le Scuole ac-
cording to the number of students involved in the 
project and the availability of a comparison school in 
the same geographical area. Only the school in the 
ASL ROMA1 respected these inclusion criteria. Con-
sequently, its referent recruited a control school from 
the same administrative area, according to geographic 
vicinity and with similar socio-demographic characteris-
tics. In this way the control school could be considered 
similar both in terms of the attending students (includ-
ing from a socio-demographic point of view), both in 
terms of its relationship with the ASL. As a matter of 
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fact, apart from the VacciniAmo le Scuole intervention, 
for every registered student of both the schools received 
yearly a personalized letter, which informs each one re-
garding his own immunization status.
The intervention school has 413 registered students, 
but only 284 participated in the VacciniAmo le Scuole 
project and have been included in this study. All the 
517 students registered in the control school have been 
included in this study.
The main outcomes were the proportion of students 
receiving each vaccination mandatory/recommended 
for adolescent, namely the 5th dose of dTap, the 2nd 
dose of MMR, a dose of HPV (among girls), one dose 
of Meningococcal C (in subjects not vaccinated dur-
ing childhood). Furthermore, because in 2015 the ASL 
ROMA1 was pursuing also the Meningococcal B vac-
cine, the proportions of students who received at least 
one dose of this vaccine were investigated as a second-
ary outcome. Finally, also the proportion of students 
receiving at least one among the above-mentioned vac-
cines has been evaluated as a secondary outcome be-
cause it represents a proxy of the opportunity to meet 
experts from the local health authority which can pro-
vide students with the best knowledge on vaccine pre-
ventable diseases for them. Because of the shifting from 
three to two doses schedule (only for the new cohorts 
of 12 years old girls whom initiated the HPV vaccina-
tion in 2015), the outcome regarding the HPV vaccine 
was considered as the initiation or the completion of 
a 2-dose HPV series. The vaccination against varicel-
la was excluded because of the impossibility to assess 
the negative history for the disease in the students. It 
should be underlined that in people aged 11 to 18 years 
the above-mentioned mandatory/recommended vac-
cinations are free of charge, while the Meningococcal 
B vaccination are offered under a discounted payment 
because in 2015 it is not yet included in the National 
Immunization Plan. 
All the outcomes were evaluated in both intervention 
and control schools just before and at 8 months since 
the implementation of the VacciniAmo le Scuole project.
Data sources 
The head of the two schools provided the student list 
with information on their school grade. Students’ cover-
age for mandatory and recommended vaccinations was 
assessed using the Local Health Authority Immuniza-
tion Register, which routinely collected data deriving 
from the national Immunization Program for residents 
within their administrative boundaries. Students were 
not counted in the analysis if they were resident in an-
other local health authority, because lack of information 
regarding immunization history and administration. 
That’s led to the exclusion of 46 non-resident students 
in the ASL ROMA1 (19 students in the intervention 
school and 27 in the control school, p = 0.393). 
The two above-mentioned data sets were merged using 
the student’s tax code as key and the observations were 
made anonymous assigning a casual numerical code.
Students’ vaccination history was ascertained before 
the program started in the intervention school (Febru-
ary, the 15th) and again after 8 months (from February, 
the 16th until October, 15th). Eight months have been 
considered as the follow-up period until the end of the 
scholastic year, giving two additional months to take 
into account that during the summer holidays parents 
could postpone the decision to vaccinate their children.
Students were considered to be already immunized if 
they had at baseline the appropriate number of doses 
for each immunization recommended in the National 
Immunization Plan (4 or 5 doses of dTap, 2 doses of 
MMR, at least 2 doses of HPV only for girls, at least 1 
dose of Meningococcal C or B). For the dTap the infor-
mation regarding the immunization status was calcu-
lated for a 4th dose, which should be completed at the 
age of 5-6 years old, and for the 5th dose, which should 
be administered every 10 years after the 4th dose (so 
around 15-16 years), but that is usually co-administered 
during the first access to the immunization center after 
11 years old to make the vaccination schedule easier. 
Among the students who were not already fully im-
munized, the ones who received the expected doses 
were recorded and a comparison between pre and post 
intervention coverage was done. For the dTap the 5th 
dose was considered the expected one and students 
that have already received it were considered fully im-
munized. 
Statistical analysis
Descriptive data were summarized through absolute 
and relative frequencies for categorical variables and 
through means and Standard Deviations (SD) for con-
tinuous variables.
Chi Square was used to compare differences between 
variables of interest at baseline. Overall and stratified 
vaccine uptake rates between the two schools were 
compared using two sample tests of proportions. Fur-
thermore, to take into account the baseline immuni-
zation coverage, the same statistical test was used to 
compare within and between differences in the vaccine 
specific pre-post immunization rates.
Statistical significance was set for p value <0.05 and 
all statistical tests were two-sided. Statistical analysis 
was performed using Intercooled Stata 12 for Macin-
tosh (Stata Corporation Lakeway, USA, 2007).
RESULTS
755 resident students in the ASL ROMA1 were in-
cluded in this study, 265 from the intervention school, 
490 from the control school. Their mean age was 12.3 
(±1.0) years and 48.1% of them were girls. The school 
grades and sex distribution did not differ between the 
two schools. At baseline, the intervention school had 
significant higher immunization rates for Meningococ-
cal B, but lower ones for the 4th dose of dTap. Among 
the 755 students, 40.4% needed 1 or more vaccines, 
significantly more in the intervention school (46.0%) 
than in the control one (37.3%). Characteristics of 
the schools as well as baseline immunization rates are 
shown in Table 1.
Table 2 reports the results of the intervention under 
study after eight months. A higher proportion of girls 
not already fully immunized for HPV received the HPV 
vaccine in the intervention group (30.5% vs 13.8%; p 
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= 0.003). Similarly, a higher proportion of students re-
ceived Meningococcal C (6.0% vs 2.0%; p = 0.005) and 
B (14.7% vs 0.3%; p <0.001) vaccines (Table 2) in the 
intervention group respect to the control. Although not 
statistically significant, a higher proportion of students 
received at least one of the mandatory/recommended 
vaccines in the intervention respect to the control 
school (41.2% vs 33.9%; p = 0.149). 
The sex and the school grade of the students not al-
ready fully immunized that received individual vaccines 
are shown in Figure 1. Only one male student of the 3rd 
year received the second dose of MMR (not shown in 
Figure 1). Excluding HPV vaccines, usually males re-
ceive more vaccinations than females (57%, 75% and 
64%, respectively for dTap, MenC and MenB). DTap 
uptake is higher in 3rd year students, while HPV and 
MenB is higher in the first class students (Figure 1). 
Lastly, we compared the immunization coverage rates 
before and after the intervention under study. Results 
reported in Table 3 are consistent with those reported in 
Table 2. The intervention school reported a significant 
increase in the HPV, Meningococcal C and B immuni-
zation rates (+11% (p = 0.002); +8.1% (p = <0.001) and 
+3.7% (p = 0.008), respectively. In particular, girls in the 
intervention school had lower HPV coverage at baseline 
(37.7% vs 45.8%), but they reached higher immuniza-
tion rates at 8 months after the project implementation 
(56.2% vs 53.3%).
DISCUSSION
Currently, most countries in the world deliver na-
tionally recommended vaccines to adolescents pri-
marily through school-based vaccination centers. This 
approach has largely overcome missed opportunities 
for vaccinating adolescents in traditional healthcare 
settings allowing higher coverage for most of the avail-
able vaccination than in delivering systems based on 
the community sector or private practice [15]. Other 
Authors highlighted that school based educational in-
tervention helped improve vaccination coverage among 
adolescents regardless of the venue of vaccination [16].
In Italy, despite this growing evidence and the large 
public offer of vaccinations, there is no national pro-
gram in place to promote vaccine uptake on a school 
level that remains globally underused with a conse-
quent inadequate access to preventive health care for 
adolescents. Nevertheless, the unexpected decrease 
in national immunization rates and the newly adopted 
National Vaccination Plan could enhance Regional and 
Local Autonomy to reinforce their efforts in this field, 
requiring country specific information regarding feasi-
bility and efficacy of tailored school programs. 
VacciniAmo le scuole is an innovative multicompo-
nent health promotion program that as been shown 
effective in improve knowledge and attitudes towards 
vaccine preventable diseases among young Italian ado-
lescents with an overall high acceptance among teach-
ers and students [13], which is in agreement with previ-
ously published papers [17]. However, no evidence was 
Table 1
Characteristics and baseline immunizazion rates of the two schools included in the study
School p
(chi2)VacciniAmo Control
Residents (N = 755) 265 490 0.393
Sex (% of Females) 130 (49.4%) (240) 48.9% 0.906
School Grade I 93 (35.9%) 163 (33.3%) 0.359
II 94 (35.9%) 158 (32.2%)
III 78 (28.2%) 169 (34.5%)
Immunization status
(Students Already 
Immunized)
dTap (4 doses) 210 (79.3%) 429 (87.6%) 0.003
dTap (5 doses) 18 (6.8%) 38 (7.8%) 0.498
MMR (2 doses) 202 (76.2%) 398 (81.2%) 0.105
HPV (at least 2 doses - females) 49 (37.7%) 110 (45.8%) 0.131
Men C (at least 1 dose) 98 (43.2%) 177 (36.1%) <0.071
Men B (at least 1 dose) 15 (5.7%) 0 (0.0%) <0.001*
Already Immunized for all the above 143 (54.0%) 307 (62.7%) 0.020
* Fisher’ exact test.
Table 2
Results of the intervention VacciniAmo le Scuole as proportion 
of students undergoing vaccination among those not already 
fully immunized *
Individual vaccines VacciniAmo 
N (%)
Control
N (%)
p
DTP 28 (11.3) 54 (11.9) 0.796
MMR 1 (1.6) 0 (0.0) 0.406**
HPV (females) 25 (30.5) 18 (13.8) 0.003
MenC 19 (14.7) 1 (0.3) <0.001**
MenB 15 (6.0) 10 (2.0) 0.005
At least One 
(DTP, MMR, HPV, 
MenC, MenB)
61 (41.2) 79 (33.9) 0.149
* The denominator of each cell is represented by the difference between 
the included students and the students already immunized with the specific 
vaccination (showed in Table 1). ** Fisher’ exact test.
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available regarding its efficacy in improving the vaccine 
uptake among program participants that is evaluated 
in this retrospective cohort study in comparison to a 
standard-of-care approach. 
Eight months since its implementation, vaccination 
coverage for most of the recommended vaccinations 
was higher in intervention school than in the con-
trol one. That’s particularly true for HPV vaccination 
among girls, but also for Meningococcal C and B vac-
cines. For all these vaccines, as already shown by dif-
ferent authors, the higher uptake has been recorded in 
younger students [15, 18]. Furthermore, we recorded 
a higher uptake of Meningococcal C and B vaccines 
among males, which has been suggested due to the 
more vaccinations required for females [19].
The   5th dose of TdaP has been required by a small 
proportion of students, mostly in the third school grade 
and without differences between the two schools, pre-
sumably because parents and students was waiting for 
the proper schedule, which is usually administered a 
couple of year later. Similarly, the 2nd dose of MMR 
vaccine is required only by one student in the inter-
vention school, with unsuccessful coverage, which re-
mained around 80% in both schools, quite far from the 
95% target identified in the national plan for eliminat-
ing measles and congenital rubella syndrome [20]. In 
this study we do not have information regarding the stu-
dents history nor the specific serum antibodies, and it 
should not be excluded that the wild disease has already 
affected most of these students. 
Additionally, despite the higher rate of students re-
ceiving at least 1 vaccine in the intervention school 
(41.2% vs 33.9%) that exceeded the control school in 
the overall coverage for all the investigated vaccines, it 
should be said that both the schools remain far from 
the national targets.  Even if we have no insight into 
why necessary vaccines were missed, one possible rea-
son relies on the fact that the vaccinations have been 
administered in a different location than in the ambu-
latory of the school. This reason should be taken into 
strong consideration when implementing a school-
based health promotion program while the opportunity 
Table 3
Within and between schools differences in the immunization coverage pre and post the intervention VacciniAmo le Scuole
Post intervention immunization coverage
(within-schools pre-post difference)
Between-schools pre-post differences
VacciniAmo P Control P VacciniAmo - Control P
dTap (5th dose) 17.0%(+10.2%) <0.001
18.8%
(+11.0%) <0.001 -0.8% 0.725
MMR (2nd dose) 76.6%(+0.4%) 0.919
81.2%
(+0.0%) 1.000 +0.4% 0.174
HPV (females) 56.2%(+18.5%) 0.003
53.3%
(+7.5%) 0.100 +11.0% 0.002
MenC 51.5%(+8.3%) 0.074
36.3%
(+0.2%) 0.947 +8.1% <0.001
MenB 11.3%(+5.7%) 0.019
2.0%
(+2.0%) 0.002 +3.7% 0.008
0
10
20
30
40
50
60
70
80
90
HPV DTP MecC MenB
Figure 1
Students not already fully immunized receiving individual vaccines, stratified according school grades (first column: black = 1st 
year; grey = 2nd year; light grey = 3rd year) and sex (second column: vertical red line = Females; horizontal light blue line = Males).
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to receive the health intervention is delayed in space 
and time [21, 23].
The success in increasingthe actual vaccination rates 
could be attributed to several factors. First, the health 
promotion intervention has been carried out using in-
novative and interactive approach, namely the role play, 
which has been very appreciated by the schools [14]. 
Secondly, the intervention has been developed in deep 
collaboration with the local health authority. For this 
reason, it is tailored according to the local needs and all 
the project team has been available to address students, 
parents and teachers’ concerns regarding vaccination 
along the project period. Finally, while most of the 
school-based programs have been focused on a specific 
vaccine (usually the HPV), this project has been devel-
oped to increase the awareness and the coverage of all 
the recommended vaccination for adolescent. 
This study has several limitations. Generalization 
should be done with caution because the setting is lim-
ited to a couple of urban schools and a small number 
of adolescents. Student’s randomization is not possible 
due to the specific school setting. Additionally, the con-
trol school has been matched as much as possible for so-
cio demographic characteristics and the two groups did 
not show significant difference at baseline for sex and 
school grade. Also the immunization status at baseline 
is quite balanced between the two schools, with some 
vaccine coverage higher in the intervention school (Me-
ningococcal C and B), but others higher in the control 
one (dTap, MMR and HPV). Finally, even if the immu-
nization registry is a high reliable source of information, 
it is limited to vaccination administered within the local 
health authority boundaries. For this reason we had to 
limit our sample to the residents within the local health 
authority and we cannot exclude, even if it is unlikely, 
we lose some information on students who decided to 
be vaccinated outside the ALS Roma 1.
This study demonstrates that the school-based mul-
ticomponent health promotion project VacciniAmo le 
Scuole was effective in improving the recommended 
vaccines among adolescents with potential interesting 
implication for the national targets attainment. Larger 
and multi-centric studies may help to understand the 
real advantages when a school-based model of immu-
nization delivery is implemented in Italy. Even thought 
Italy has recently passed a law to make mandatory 10 
vaccinations and to make vaccination a school require-
ments for children under the age of 16, multicompo-
nent school based immunization campaigns could be 
helpful to overcome several well-known barriers to ado-
lescent immunization, such as the need for parents to 
miss work or the opportunity for the ASL to get in touch 
with a hard-to-reach target, as well as to increase the 
population confidence in the health institutions [24].
CONCLUSIONS
Our results suggest that innovative school-based 
health promotion intervention could increase adoles-
cent specific vaccination uptakes and coverage. The 
Local Health Authorities should implement and evalu-
ate similar school-based interventions to give Italian 
students trustworthy information regarding vaccination 
and, consequently, being protected against vaccine pre-
ventable diseases. Better results could be reach offering 
the vaccination in school facilities. 
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